Volume 25, Issue 11-12 pp. 597-608

Consumption of L-arginine mediated by Entamoeba histolytica L-arginase (EhArg) inhibits amoebicidal activity and nitric oxide production by activated macrophages

Keren Elnekave

Keren Elnekave

Department of Molecular Microbiology, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel

Search for more papers by this author
Rama Siman-Tov

Rama Siman-Tov

Department of Molecular Microbiology, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel

Search for more papers by this author
Serge Ankri

Corresponding Author

Serge Ankri

Department of Molecular Microbiology, The Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel

Serge Ankri, Department of Molecular Microbiology, The Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, P.O.B. 9649, 31096 Haifa, Israel (e-mail: [email protected]).Search for more papers by this author
First published: 23 March 2004
Citations: 48

SUMMARY

In this study we discuss the cloning and expression of Entamoeba histolytica arginase (EhArg), an enzyme that catalyses the hydrolysis of l-arginine to l-ornithine and urea. l-norvaline, a competitive inhibitor of E. histolytica l-arginase, inhibits the growth of the parasite, which suggests that the catabolism of l-arginine mediated by EhArg is essential. Nitric oxide (NO) is an antimicrobial agent that inhibits some key enzymes in the metabolism of Entamoeba histolytica. NO is synthesized by activated macrophages from l-arginine, the substrate of NO synthase (NOS-II). We show that E. histolytica inhibits NO mediated amoebicidal activity of activated macrophages by consuming l-arginine present in the medium.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.